179 related articles for article (PubMed ID: 38705566)
1. LILRB2 inhibition enhances radiation sensitivity in non-small cell lung cancer by attenuating radiation-induced senescence.
Chen X; Yuan M; Zhong T; Wang M; Wu F; Lu J; Sun D; Xiao C; Sun Y; Hu Y; Wu M; Wang L; Yu J; Chen D
Cancer Lett; 2024 Jul; 593():216930. PubMed ID: 38705566
[TBL] [Abstract][Full Text] [Related]
2. Aryl hydrocarbon receptor mediates Jak2/STAT3 signaling for non-small cell lung cancer stem cell maintenance.
Xiong J; Zhang X; Zhang Y; Wu B; Fang L; Wang N; Yi H; Chang N; Chen L; Zhang J
Exp Cell Res; 2020 Nov; 396(1):112288. PubMed ID: 32941808
[TBL] [Abstract][Full Text] [Related]
3. Mogrol-mediated enhancement of radiotherapy sensitivity in non-small cell lung cancer: a mechanistic study.
Yin Z; Zhang X; Sun X; Huo Y; Ji N; Chen K
Am J Physiol Cell Physiol; 2024 Jun; 326(6):C1753-C1768. PubMed ID: 38682239
[TBL] [Abstract][Full Text] [Related]
4. MiR-124 Inhibits Growth and Enhances Radiation-Induced Apoptosis in Non-Small Cell Lung Cancer by Inhibiting STAT3.
Wang M; Meng B; Liu Y; Yu J; Chen Q; Liu Y
Cell Physiol Biochem; 2017; 44(5):2017-2028. PubMed ID: 29237164
[TBL] [Abstract][Full Text] [Related]
5. MiR-181a reduces radiosensitivity of non-small-cell lung cancer via inhibiting PTEN.
Chen Y; Liao W; Yuan A; Xu H; Yuan R; Cao J
Panminerva Med; 2022 Sep; 64(3):374-383. PubMed ID: 32506887
[TBL] [Abstract][Full Text] [Related]
6. ANGPTL2/LILRB2 signaling promotes the propagation of lung cancer cells.
Liu X; Yu X; Xie J; Zhan M; Yu Z; Xie L; Zeng H; Zhang F; Chen G; Yi X; Zheng J
Oncotarget; 2015 Aug; 6(25):21004-15. PubMed ID: 26056041
[TBL] [Abstract][Full Text] [Related]
7. LncRNA SBF2-AS1 affects the radiosensitivity of non-small cell lung cancer via modulating microRNA-302a/MBNL3 axis.
Yu Z; Wang G; Zhang C; Liu Y; Chen W; Wang H; Liu H
Cell Cycle; 2020 Feb; 19(3):300-316. PubMed ID: 31928130
[No Abstract] [Full Text] [Related]
8. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
9. Over-regulation of microRNA-133b inhibits cell proliferation of cisplatin-induced non-small cell lung cancer cells through PI3K/Akt and JAK2/STAT3 signaling pathway by targeting EGFR.
Li B; Ding CM; Li YX; Peng JC; Geng N; Qin WW
Oncol Rep; 2018 Mar; 39(3):1227-1234. PubMed ID: 29344640
[TBL] [Abstract][Full Text] [Related]
10. TP53 drives abscopal effect by secretion of senescence-associated molecular signals in non-small cell lung cancer.
Tesei A; Arienti C; Bossi G; Santi S; De Santis I; Bevilacqua A; Zanoni M; Pignatta S; Cortesi M; Zamagni A; Storci G; Bonafè M; Sarnelli A; Romeo A; Cavallo C; Bartolazzi A; Rossi S; Soriani A; Strigari L
J Exp Clin Cancer Res; 2021 Mar; 40(1):89. PubMed ID: 33673859
[TBL] [Abstract][Full Text] [Related]
11. Inhibition on Numb/Notch signal pathway enhances radiosensitivity of lung cancer cell line H358.
Song SG; Yu HY; Ma YW; Zhang F; Xu XY
Tumour Biol; 2016 Oct; 37(10):13705-13719. PubMed ID: 27476167
[TBL] [Abstract][Full Text] [Related]
12. Role of microRNA-21 in radiosensitivity in non-small cell lung cancer cells by targeting PDCD4 gene.
Jiang LP; He CY; Zhu ZT
Oncotarget; 2017 Apr; 8(14):23675-23689. PubMed ID: 28423589
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of JAK2 signaling by TG101209 enhances radiotherapy in lung cancer models.
Sun Y; Moretti L; Giacalone NJ; Schleicher S; Speirs CK; Carbone DP; Lu B
J Thorac Oncol; 2011 Apr; 6(4):699-706. PubMed ID: 21325979
[TBL] [Abstract][Full Text] [Related]
14. MiR-365 enhances the radiosensitivity of non-small cell lung cancer cells through targeting CDC25A.
Li H; Jiang M; Cui M; Feng G; Dong J; Li Y; Xiao H; Fan S
Biochem Biophys Res Commun; 2019 Apr; 512(2):392-398. PubMed ID: 30902389
[TBL] [Abstract][Full Text] [Related]
15. SIRT6 through PI3K/Akt/mTOR signaling pathway to enhance radiosensitivity of non-Small cell lung cancer and inhibit tumor progression.
Xiong L; Tan B; Lei X; Zhang B; Li W; Liu D; Xia T
IUBMB Life; 2021 Sep; 73(9):1092-1102. PubMed ID: 34033225
[TBL] [Abstract][Full Text] [Related]
16. Physalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signaling.
Zhu F; Dai C; Fu Y; Loo JF; Xia D; Gao SP; Ma Z; Chen Z
Oncotarget; 2016 Feb; 7(8):9462-76. PubMed ID: 26843613
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of Lncrna PVT1 Enhances Radiosensitivity in Non-Small Cell Lung Cancer by Sponging Mir-195.
Wu D; Li Y; Zhang H; Hu X
Cell Physiol Biochem; 2017; 42(6):2453-2466. PubMed ID: 28848163
[TBL] [Abstract][Full Text] [Related]
18. ILT3 promotes tumor cell motility and angiogenesis in non-small cell lung cancer.
Li J; Gao A; Zhang F; Wang S; Wang J; Wang J; Han S; Yang Z; Chen X; Fang Y; Jiang G; Sun Y
Cancer Lett; 2021 Mar; 501():263-276. PubMed ID: 33152402
[TBL] [Abstract][Full Text] [Related]
19. Integrin αVβ1-activated PYK2 promotes the progression of non-small-cell lung cancer via the STAT3-VGF axis.
Wu Z; Jiao M; Shu C; Zhang S; Wang J; Pu J; Zhu J; Zeng Y; Zhu Y; Liu Z
Cell Commun Signal; 2024 Jun; 22(1):313. PubMed ID: 38844957
[TBL] [Abstract][Full Text] [Related]
20. miR-210 transferred by lung cancer cell-derived exosomes may act as proangiogenic factor in cancer-associated fibroblasts by modulating JAK2/STAT3 pathway.
Fan J; Xu G; Chang Z; Zhu L; Yao J
Clin Sci (Lond); 2020 Apr; 134(7):807-825. PubMed ID: 32219336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
